Is Merck Stock A Buy As Moderna Investment Pays Off?
Things are looking up for Merck stock after the Big Pharma bellwether easily topped third-quarter expectations, signed a deal to develop a cancer treatment with Moderna (MRNA) and agreed to a $1.35 billion acquisition of Imago BioSciences (IMGO). In mid-December, Merck (MRK) shares advanced again…#merck #pah #kelunbiotech #mrk #imagobiosciences #acceleronpharma #modernastockabuy #gardasil #imago #seagen (Source: Reuters: Health)
Source: Reuters: Health - January 14, 2023 Category: Consumer Health News Source Type: news

10 Ways the World Got Better In 2022
Over the past year, the headlines have been dominated by alarming events: the Russian invasion of Ukraine, high inflation, supply chain shortages, and the threat of food insecurity for many nations. But 2022 was also a year of milestones toward a better future, scientific breakthroughs, and stories of hope. Here’s a look at 10 stories of human progress from the last 12 months. 1. We found out that civilization reached peak agricultural land For nearly all of human history, producing more food required more land. But starting in the early 1900s, and continuing through the next 100 years, four powerful forces—syn...
Source: TIME: Health - December 28, 2022 Category: Consumer Health News Authors: Tony Morley Tags: Uncategorized climate change freelance global health Health Care healthscienceclimate Londontime Source Type: news

Gardasil 9 HPV Vaccine Advised for MSM Living With HIV Gardasil 9 HPV Vaccine Advised for MSM Living With HIV
Italian researchers say the HPV vaccine is needed in young MSM with gonorrhea exposure. The WHO says only 30% of the target population worldwide has received the HPV vaccine.Medscape Medical News (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - October 3, 2022 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news

Thousands report unusual menstruation patterns after COVID-19 vaccination
Kathryn Clancy got her first dose of a COVID-19 vaccine in early 2021 and 10 days later found herself sitting uncomfortably in a work Zoom meeting during one of the heaviest periods she’d experienced. “I had what’s often called menstrual flooding,” says Clancy, a biological anthropologist at the University of Illinois, Urbana-Champaign. Clancy wouldn’t have thought to connect the experience to the Moderna dose she’d received were it not for her graduate student, Katharine Lee, now at Tulane University, who shared a similar tale. “I had the worst cramps of my life” after COVID-19 vaccination, Lee says. Intri...
Source: ScienceNOW - July 15, 2022 Category: Science Source Type: news

Why More Kids Aren ’t Getting the HPV Vaccine
The human papillomavirus vaccine can prevent six potentially lethal malignancies, but inoculation is meeting with rising resistance from parents. (Source: NYT Health)
Source: NYT Health - December 13, 2021 Category: Consumer Health News Authors: Jane E. Brody Tags: Human Papillomavirus (HPV) Gardasil (Vaccine) Cervical Cancer Vaccination and Immunization Head and Neck Cancer Sexually Transmitted Diseases Parenting Teenagers and Adolescence Youth Cervarix (Vaccine) JAMA Pediatrics (Journal) Source Type: news

Tanzania: Send Your Daughters for Hpv Vaccination, Parents Urged
[Daily News] THE MINISTRY of Health, Community Development, Gender, Elderly and Children has urged parents to ensure that their daughters take the Human Papillomavirus Vaccine (HPV) to protect them from cervical cancer. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - December 1, 2021 Category: African Health Source Type: news

HPV Vaccine Has Protected Thousands Of People From Cervical Cancer, According To New Study
The HPV (human papillomavirus) vaccine pledged to help protect students between the ages of 12 and 13 from cervical cancer, among other cancers. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 1, 2021 Category: Pharmaceuticals Authors: Alice Broster, Contributor Tags: Healthcare /healthcare Innovation /innovation Source Type: news

Schools Could Help More Kids Get the COVID-19 Vaccine. But History Has Some Warnings
Now that the U.S. Food and Drug Administration has authorized Pfizer-BioNTech’s vaccine for kids aged 5 to 11, the Biden Administration has signaled that it will rely on a “trusted messenger” to get information to parents and provide access to vaccines once they’re approved by the Centers for Disease Control and Prevention: schools. As part of the plan to deliver COVID-19 vaccines to the youngest population yet, schools will again take on a role they’ve assumed during health crises throughout American history: promoting vaccination to keep kids and communities safe from infectious disease. &ld...
Source: TIME: Science - November 1, 2021 Category: Science Authors: Tara Law Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news

Schools Could Help More Kids Get the COVID-19 Vaccine. But History Has Some Warnings
Now that the U.S. Food and Drug Administration has authorized Pfizer-BioNTech’s vaccine for kids aged 5 to 11, the Biden Administration has signaled that it will rely on a “trusted messenger” to get information to parents and provide access to vaccines once they’re approved by the Centers for Disease Control and Prevention: schools. As part of the plan to deliver COVID-19 vaccines to the youngest population yet, schools will again take on a role they’ve assumed during health crises throughout American history: promoting vaccination to keep kids and communities safe from infectious disease. &ld...
Source: TIME: Health - November 1, 2021 Category: Consumer Health News Authors: Tara Law Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news

MSD Pharmaceuticals launches gender-neutral HPV vaccine GARDASIL 9 in India
"Launching GARDASIL 9 is a crucial step towards advancing the mission of building a healthy young India by reducing the disease burden of HPV-related cancers and disease in the country," MSD India Region Managing Director Rehan A Khan said in a statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 29, 2021 Category: Pharmaceuticals Source Type: news

Quickstats: Percentage of Adults Aged 18-26 Years Who Ever Received a Human Papillomavirus Vaccine, by Race and Hispanic Origin and Sex - National Health Interview Survey, United States, 2019
This report describes the percentage of adults aged 18-26 years who received a human papillomavirus vaccine, by race and Hispanic origin and sex. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - May 27, 2021 Category: American Health Tags: Adult Vaccinations HPV Infection (Human Papillomavirus) HPV Vaccination (Human Papillomavirus) MMWR Morbidity & Mortality Weekly Report Source Type: news

HPV vaccine has led to more than 80% drop in infections, CDC reports
Introduction of the human papillomavirus vaccine in the United States has led to a more than 80% decline in infections nationally since 2003, according to data released Thursday by the CDC. (Source: Health News - UPI.com)
Source: Health News - UPI.com - March 25, 2021 Category: Consumer Health News Source Type: news

Declines in Prevalence of Human Papillomavirus Vaccine-Type Infection Among Females after Introduction of Vaccine - United States, 2003-2018
This report describes declines in HPV vaccine-type infection prevalence among females when compared with prevalence before vaccination. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - March 25, 2021 Category: American Health Tags: MMWR Morbidity & Mortality Weekly Report Source Type: news

We All Deserve Protection From Covid-19
Credit: United NationsBy Adaora OkoliNEW ORLEANS, US, Dec 11 2020 (IPS) When I contracted Ebola virus disease in August 2014 while working as a medical doctor in a well-known private hospital in Lagos, Nigeria, I was denied access to a potential cure. For 15 days, I battled for my life in a debilitated isolation ward, not knowing if I would survive. But American aid workers who contracted Ebola were administered Zmapp, a monoclonal antibody treatment, which reduces the relative risk of death from Ebola by 40% as well as shorten the duration of stay in the Ebola treatment units. They survived. We were told that Zmapp was e...
Source: IPS Inter Press Service - Health - December 11, 2020 Category: International Medicine & Public Health Authors: Adaora Okoli Tags: Headlines Health TerraViva United Nations Source Type: news

School HPV vaccine policies could result in higher vaccination rates, reduction in cancers
FINDINGSA UCLA-led study has found that in 2 of 3 states and jurisdictions with policies that require students entering school to receive the human papillomavirus vaccine, vaccination rates among 13-to-17-year-olds were significantly higher than in surrounding states without such policies.In Rhode Island, the vaccination rate among adolescents was 91%, compared with an average of 78% in neighboring non-policy states. In the District of Columbia, the rate was 89%, compared with 72% for nearby non-policy states. Virginia, which is in the same region as the district, was the one state with a vaccination policy that showed no ...
Source: UCLA Newsroom: Health Sciences - June 29, 2020 Category: Universities & Medical Training Source Type: news